117 results
8-K
EX-99.1
BFRI
Biofrontera Inc
15 May 24
Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update
5:20pm
)
Loss before income taxes
Income tax expense
Net loss
Loss per common share:
Basic and diluted
Weighted-average common shares outstanding:
Basic … )
Three Months Ended March 31,
Net loss
Interest expense, net
Income tax expenses
Depreciation and amortization
EBITDA
Loss on debt extinguishment
Change
DEFR14A
BFRI
Biofrontera Inc
30 Apr 24
Revised proxy
4:35pm
by the listing rules of The Nasdaq Stock Market and in order to ensure favorable federal income tax treatment for grants of incentive stock options … to satisfy a tax withholding obligation or that are withheld to pay all or a portion of an option’s exercise price will again become available
8-K
EX-99.1
d8sw7n8ick882cmbr
15 Mar 24
Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
5:20pm
8-K
EX-10.2
3upli9dmyvf6r12i
23 Feb 24
Biofrontera Inc. Announces Closing of Private Placement of Up To $16.0 Million priced at market per Nasdaq rules
9:26am
8-K
EX-4.1
6unhrf me6qq
23 Feb 24
Biofrontera Inc. Announces Closing of Private Placement of Up To $16.0 Million priced at market per Nasdaq rules
9:26am
8-K
EX-3.1
b6of2hn gskkiw01v
23 Feb 24
Biofrontera Inc. Announces Closing of Private Placement of Up To $16.0 Million priced at market per Nasdaq rules
9:26am
8-K
EX-10.1
len 92h627hbef
23 Feb 24
Biofrontera Inc. Announces Closing of Private Placement of Up To $16.0 Million priced at market per Nasdaq rules
9:26am
8-K
EX-10.1
n16e4req4lxbpa2
20 Feb 24
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG
9:37am